Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Aspire Health vs GobyMeds

GobyMeds costs $4 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Aspire Health logo

Aspire Health

8.9
★★★★★4.5/5

Best for: a published price you can check dose by dose before handing over any health information

Visit Aspire Health →
VS
GobyMeds logo

GobyMeds

8.3
★★★★☆4.2/5

Best for: moving between compounded and brand without changing seller

Visit GobyMeds →

If you are choosing between Aspire Health and GobyMeds, the first difference is cost: GobyMeds is $4 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Aspire Health leads our six-part score, 8.9 to 8.3.

Aspire Health vs GobyMeds price

GobyMeds is the cheaper way in: $99 a month against $103 a month at Aspire Health. That is $4 less each month (4% lower), or about $48 over a year of treatment.

Drug by drug: Semaglutide is cheaper at GobyMeds ($99 a month vs $103 a month); tirzepatide is cheaper at GobyMeds ($133 a month vs $149 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and brand-name pens.

Where each one treats patients

Aspire Health lists 29 states, and GobyMeds does not publish where it ships.

Pricing

Aspire Health

0.5 mg weekly, 5‑week vialCompounded
$103/mo
semaglutide

$129 for one vial, which Aspire's table says covers 5 weeks at 0.5 mg a week — about $103/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free. Aspire also lists a 0.25 mg starting-dose vial at $129 that its table says covers ten weeks, about $52/month; that is the titration starting rung, not a rate anyone stays on.

1 mg weekly, 5‑week vialCompounded
$127/mo
semaglutide

$159 for one vial, which Aspire's table says covers 5 weeks at 1 mg a week — about $127/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

1.7 mg weekly, 5.8‑week vialCompounded
$130/mo
semaglutide

$189 for one vial, which Aspire's table says covers 5.8 weeks at 1.7 mg a week — about $130/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

2.4 mg weekly, 4.1‑week vialCompounded
$184/mo
semaglutide

$189 for one vial, which Aspire's table says covers 4.1 weeks at 2.4 mg a week — about $184/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

2.5 mg weekly (starting dose), 4‑week vialCompounded
$149/mo
tirzepatide

$149 for one vial covering 4 weeks at the 2.5 mg starting dose. This is the titration starting rung only. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

5 mg weekly, 4‑week vialCompounded
$249/mo
tirzepatide

$249 for one vial, which Aspire's table says covers 4 weeks at 5 mg a week — about $249/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

7.5 mg weekly, 5.3‑week vialCompounded
$211/mo
tirzepatide

$279 for one vial, which Aspire's table says covers 5.3 weeks at 7.5 mg a week — about $211/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

10 mg weekly, 5‑week vialCompounded
$231/mo
tirzepatide

$289 for one vial, which Aspire's table says covers 5 weeks at 10 mg a week — about $231/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

12.5 mg weekly, 4.8‑week vialCompounded
$249/mo
tirzepatide

$299 for one vial, which Aspire's table says covers 4.8 weeks at 12.5 mg a week — about $249/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

15 mg weekly, 4‑week vialCompounded
$299/mo
tirzepatide

$299 for one vial, which Aspire's table says covers 4 weeks at 15 mg a week — about $299/month of medication. Two and three vials cost exactly 2x and 3x one vial, so there is no bundle discount. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Brand Wegovy, 0.25‑0.5 mg, 4‑week supplyBrand-name
$199/mo
semaglutide

$199 for a 4‑week supply of brand Wegovy at this dose, from Aspire's published table. Aspire adds that pricing varies with insurance coverage and that patients should verify benefits directly. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Brand Wegovy, all other doses, 4‑week supplyBrand-name
$399/mo
semaglutide

$399 for a 4‑week supply of brand Wegovy at this dose, from Aspire's published table. Aspire adds that pricing varies with insurance coverage and that patients should verify benefits directly. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Brand Zepbound, 2.5 mg, 4‑week supplyBrand-name
$299/mo
tirzepatide

$299 for a 4‑week supply of brand Zepbound at this dose, from Aspire's published table. Aspire adds that pricing varies with insurance coverage and that patients should verify benefits directly. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Brand Zepbound, 5 mg, 4‑week supplyBrand-name
$399/mo
tirzepatide

$399 for a 4‑week supply of brand Zepbound at this dose, from Aspire's published table. Aspire adds that pricing varies with insurance coverage and that patients should verify benefits directly. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Brand Zepbound, all other doses, 4‑week supplyBrand-name
$449/mo
tirzepatide

$449 for a 4‑week supply of brand Zepbound at this dose, from Aspire's published table. Aspire adds that pricing varies with insurance coverage and that patients should verify benefits directly. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Oral Wegovy, 1.5 mg / 4 mgBrand-name
$149/mo
semaglutide

$149/month for oral Wegovy at this dose, published by Aspire as a monthly figure. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

Oral Wegovy, 9 mg / 25 mgBrand-name
$299/mo
semaglutide

$299/month for oral Wegovy at this dose, published by Aspire as a monthly figure. Medication only. Aspire's 'Monthly Medical Care' fee of $49/month is billed separately and is mandatory for as long as therapy continues; the new‑patient consultation is free.

GobyMeds

3-Month Starter Bundle (first-time patients)Compounded
$99$93/mo
Save 6% right now
semaglutide

$299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo) — promo end-dated Dec 31 2025 but still displayed July 2026

12-Week Bundle, plans reaching 0.2–1.5 mgCompounded
$133/mo
semaglutide

$399 total / 12 weeks

12-Week Bundle, plans reaching 1.9–2.3 mgCompounded
$166$146/mo
Save 12% right now
semaglutide

$499 total / 12 weeks; JUMPSTART PROMO PRICE $439 ($146/month) shown under the higher-dose block

Single month, any dosageCompounded
$169$159/mo
Save 6% right now
semaglutide

JUMPSTART20 promo $159

Starter Plan – 3 month (first-time patients)Compounded
$133/mo
tirzepatide

$399 total for 12 weeks incl. medication, shipping, consultation, injection kit; promo price shown unchanged at $399

12-Week Bundle, plans reaching up to 9 mg/weekCompounded
$166/mo
tirzepatide

$499 total / 12 weeks

12-Week Bundle, plans reaching 11 mg/week or higherCompounded
$200$160/mo
Save 20% right now
tirzepatide

$599 total / 12 weeks; JUMPSTART PROMO PRICE $479+ (price dependent on dose)

Single month, any dosageCompounded
$299$279/mo
Save 7% right now
tirzepatide

Primary pricing block says $299 (promo $279); a duplicated template block on the same page shows $349 — site inconsistency

monthlyBrand-name
$1399/mo
tirzepatide (zepbound)

Promo codes 'not valid on Zepbound and Wegovy'

monthlyBrand-name
$1695/mo
semaglutide (wegovy)

Promo codes 'not valid on Zepbound and Wegovy'

What each price covers

Both prices cover the clinician visit and the medication itself.

Aspire Health's price also covers coaching, which GobyMeds does not claim.

GobyMeds' price also covers shipping, which Aspire Health does not claim.

Aspire Health is silent on shipping.

GobyMeds is silent on lab work and coaching.

Aspire Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Charged on top

Coaching

In the price

GobyMeds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Aspire Health scores 8.9 and GobyMeds 8.3 out of 10.

Aspire Health is stronger on trust & safety (10.0 vs 6.5) and accessibility (6.6 vs 5.0).

Value, effectiveness, user experience and support are within half a point.

How we score

Aspire Health

8.9/10

Overall

GobyMeds

8.3/10

Value25%

9.2A
vs
B
9.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
6.5

Accessibility10%

6.6A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither Aspire Health nor GobyMeds has an FDA warning letter on record with us.

Features & Coverage

FeatureAspire HealthGobyMeds
Starting Price$103/mo✓$99/mo
Features✓8 features2 features
States Available29Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Aspire Health

Aspire Health is a Nebraska‑based telehealth practice that publishes dose‑by‑dose prices before any intake. Compounded semaglutide works out to about $103/month at 0.5 mg and $184 at the 2.4 mg maintenance dose; compounded tirzepatide is about $249/month at 5 mg. Brand Wegovy, brand Zepbound and oral Wegovy are priced separately. Medication is billed on top of a $49/month medical‑care fee, and the cost of lab work is not included. A named PA/NP team prescribes, and all three dispensing pharmacies are named publicly.

Read our full Aspire Health review →

About GobyMeds

GobyMeds is a low-cost telehealth seller. Compounded semaglutide is the only medication it offers.

Read our full GobyMeds review →

Pros & Cons

Aspire Health

What we like

  • Semaglutide costs $103 a month, 44% below the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $211 a month, 16% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and coaching
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to Aspire Health

Watch-outs

  • Not included in the monthly price: lab work
  • Serves only 29 states, so check that yours is one of them
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

GobyMeds

What we like

  • Semaglutide costs $99 a month, 46% below the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $133 a month, 47% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to GobyMeds

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Aspire Health

Aspire Health wins this one, 8.9 to 8.3, above all for a published price you can check dose by dose before handing over any health information. GobyMeds undercuts it by $4 a month, so if the monthly bill is what decides it, GobyMeds is the pick. GobyMeds fits better if moving between compounded and brand without changing seller is your priority.

Choose Aspire Health if…

You want a published price you can check dose by dose before handing over any health information and an opening price near $103 a month.

Choose GobyMeds if…

You want moving between compounded and brand without changing seller and an opening price near $99 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

Aspire Health vs GobyMeds: FAQ

GobyMeds. It starts at $99 a month; Aspire Health starts at $103 a month, $4 more per month.
Yes, both sell semaglutide and tirzepatide.
Aspire Health lists 29 states; GobyMeds does not publish where it ships. Confirm your state before paying.
Both include the clinician visit and the medication itself. Only Aspire Health includes coaching. Only GobyMeds includes shipping.
Aspire Health has none. GobyMeds has none.
No. Neither Aspire Health nor GobyMeds pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.